Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ

$13.75

$+0.11

(+0.81%)

Pre-Market

4D Molecular Therapeutics, Inc. (FDMT) Live Price Chart

Last updated: ⁦2026-09-16 10:31:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

4D Molecular Therapeutics, Inc. (FDMT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $13.75, with a market capitalisation of $760.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.47 to $16.93. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$760.16M
Open	$13.64
Day's High	$55.11
Day's Low	$2.24
Previous Close	$13.63
Volume	360.00
Average Volume	938.82K
P/E Ratio	--
52-Week High	$16.93
52-Week Low	$6.47
Dividend Yield	--
Earnings Date	--

4D Molecular Therapeutics, Inc. (FDMT) Pre-Market Stock Price

4D Molecular Therapeutics, Inc. (FDMT) is trading at $13.75 in pre-market trading as of 2026-09-16 10:24:00, up 0.89% ($0.12) from the previous close of $13.63

Pre-market trading shows how investors are pricing FDMT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

4D Molecular Therapeutics, Inc. (FDMT) 7-Day Stock Price Change

Over the past seven days, 4D Molecular Therapeutics, Inc. (FDMT) moved from $14.97 to $13.75, representing a decline of 8.14% ($1.22).

The stock traded between $12.94 and $15.29 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 576.17 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

FDMT 52-Week Price Position

Position in Range: 69.6%

52W Low$6.47

52W High$16.93

FDMT is currently trading at $13.75, placing it 69.6% of the way from its 52-week low of $6.47 to its 52-week high of $16.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is 4D Molecular Therapeutics, Inc. (FDMT)?

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

4D Molecular Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	196
Exchange	NASDAQ
Company Website	https://www.4dmoleculartherapeutics.com

How to Buy 4D Molecular Therapeutics, Inc. (FDMT) Stock on MEXC

Eligible investors can buy real shares of 4D Molecular Therapeutics, Inc. (FDMT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FDMT and Place Your Order

Open the RealStocks trading page and search for FDMT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is 4D Molecular Therapeutics, Inc. (FDMT) stock price today?

4D Molecular Therapeutics, Inc. (FDMT) is currently trading at $ 13.75, up 0.89% ($0.12) from the previous close of $ 13.63. Intraday prices update in real time during regular trading hours.

2.Is FDMT stock going up or down today?

As of 2026-09-16 10:24:00, FDMT is trading at $ 13.75, up 0.89% ($0.12) from its previous close of $ 13.63. The stock has traded between $ 2.24 and $ 55.11 during today’s regular session. Past price movements do not guarantee future results.

3.What is FDMT pre-market price?

As of 2026-09-16 10:24:00, FDMT is trading at $ 13.75 in pre-market trading, up 0.89% ($0.12) from the previous close of $ 13.63. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FDMT after-hours price?

As of 2026-09-16 10:24:00, FDMT is trading at $ 13.64 in after-hours trading, up 0.07% ($0.01) from the regular-session close of $ 13.63. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FDMT stock trading now?

FDMT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FDMT sit relative to its 52-week high and low?

Over the past 52 weeks, FDMT has traded between a low of $ 6.47 and a high of $ 16.93. At $ 13.75, the stock is positioned 69.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is 4D Molecular Therapeutics, Inc. in?

4D Molecular Therapeutics, Inc. (FDMT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is 4D Molecular Therapeutics, Inc.'s market capitalisation and where is it listed?

4D Molecular Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 760.16M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FDMT valued in terms of P/E ratio and EPS?

FDMT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.24. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does 4D Molecular Therapeutics, Inc. pay a dividend?

4D Molecular Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.